234 related articles for article (PubMed ID: 21292815)
1. Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.
Heffernan KS; Kuvin JT; Sarnak MJ; Perrone RD; Miskulin DC; Rudym D; Chandra P; Karas RH; Menon V
Nephrol Dial Transplant; 2011 Aug; 26(8):2515-21. PubMed ID: 21292815
[TBL] [Abstract][Full Text] [Related]
2. Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease.
Menon V; Rudym D; Chandra P; Miskulin D; Perrone R; Sarnak M
Clin J Am Soc Nephrol; 2011 Jan; 6(1):7-13. PubMed ID: 20829421
[TBL] [Abstract][Full Text] [Related]
3. Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function.
Borresen ML; Wang D; Strandgaard S
Am J Nephrol; 2007; 27(3):240-6. PubMed ID: 17389784
[TBL] [Abstract][Full Text] [Related]
4. Vascular Dysfunction, Oxidative Stress, and Inflammation in Autosomal Dominant Polycystic Kidney Disease.
Nowak KL; Wang W; Farmer-Bailey H; Gitomer B; Malaczewski M; Klawitter J; Jovanovich A; Chonchol M
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1493-1501. PubMed ID: 30228110
[TBL] [Abstract][Full Text] [Related]
5. Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients.
Sans L; Pascual J; Radosevic A; Quintian C; Ble M; Molina L; Mojal S; Ballarin JA; Torra R; Fernández-Llama P
Medicine (Baltimore); 2016 Dec; 95(49):e5595. PubMed ID: 27930582
[TBL] [Abstract][Full Text] [Related]
6. Serum Fas Ligand, Serum Myostatin and Urine TGF-β1 Are Elevated in Autosomal Dominant Polycystic Kidney Disease Patients with Impaired and Preserved Renal Function.
Raptis V; Bakogiannis C; Loutradis C; Boutou AK; Sioulis A; Balaskas E; Zebekakis P; Sarafidis PA
Kidney Blood Press Res; 2018; 43(3):744-754. PubMed ID: 29794429
[TBL] [Abstract][Full Text] [Related]
7. Mean platelet volume and its relation with arterial stiffness in patients with normotensive polycystic kidney disease.
Orscelik O; Kocyigit I; Akpek M; Dogdu O; Kaya C; Unal A; Sipahioglu M; Tokgoz B; Zengin H; Oymak O; Kaya MG
J Investig Med; 2013 Mar; 61(3):597-603. PubMed ID: 23360844
[TBL] [Abstract][Full Text] [Related]
8. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
Messchendorp AL; Meijer E; Visser FW; Engels GE; Kappert P; Losekoot M; Peters DJM; Gansevoort RT;
Am J Nephrol; 2019; 50(5):375-385. PubMed ID: 31600749
[TBL] [Abstract][Full Text] [Related]
9. The association of endothelin-1 levels with renal survival in polycystic kidney disease patients.
Kocyigit I; Eroglu E; Kaynar AS; Kocer D; Kargi S; Zararsiz G; Bayramov R; Imamoglu H; Sipahioglu MH; Tokgoz B; Dundar M; Oymak O
J Nephrol; 2019 Feb; 32(1):83-91. PubMed ID: 30022320
[TBL] [Abstract][Full Text] [Related]
10. Association of OSR-1 With Vascular Dysfunction and Hypertension in Polycystic Kidney Disease.
Kocyigit I; Taheri S; Eroglu E; Zararsiz G; Sener EF; Uzun I; Imamoglu H; Mehmetbeyoglu E; Unal A; Korkmaz K; Sipahioglu MH; Oymak O; Tokgoz B
Ther Apher Dial; 2020 Feb; 24(1):64-71. PubMed ID: 31020807
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction and oxidative stress in polycystic kidney disease.
Klawitter J; Reed-Gitomer BY; McFann K; Pennington A; Klawitter J; Abebe KZ; Klepacki J; Cadnapaphornchai MA; Brosnahan G; Chonchol M; Christians U; Schrier RW
Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1198-206. PubMed ID: 25234311
[TBL] [Abstract][Full Text] [Related]
12. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
[TBL] [Abstract][Full Text] [Related]
13. Alterations of Proximal Tubular Secretion in Autosomal Dominant Polycystic Kidney Disease.
Wang K; Zelnick LR; Chen Y; Hoofnagle AN; Watnick T; Seliger S; Kestenbaum B
Clin J Am Soc Nephrol; 2020 Jan; 15(1):80-88. PubMed ID: 31628117
[TBL] [Abstract][Full Text] [Related]
14. Kidney Function Reserve Capacity in Early and Later Stage Autosomal Dominant Polycystic Kidney Disease.
Messchendorp AL; van Londen M; Taylor JM; de Borst MH; Navis G; Casteleijn NF; Gaillard CAJM; Bakker SJL; Gansevoort RT;
Clin J Am Soc Nephrol; 2018 Nov; 13(11):1680-1692. PubMed ID: 30254028
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease.
Nowak KL; Cadnapaphornchai MA; Chonchol MB; Schrier RW; Gitomer B
Am J Nephrol; 2016; 44(3):171-8. PubMed ID: 27548646
[TBL] [Abstract][Full Text] [Related]
16. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
Coban M; Inci A
Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
[TBL] [Abstract][Full Text] [Related]
17. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
Spithoven EM; Meijer E; Boertien WE; Sinkeler SJ; Tent H; de Jong PE; Navis G; Gansevoort RT
Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
[TBL] [Abstract][Full Text] [Related]
18. Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients.
Kocyigit I; Kaya MG; Orscelik O; Kaya C; Akpek M; Zengin H; Sipahioglu MH; Unal A; Yilmaz MI; Tokgoz B; Oymak O; Axelsson J
Am J Nephrol; 2012; 36(1):11-8. PubMed ID: 22699414
[TBL] [Abstract][Full Text] [Related]
19. Nutritional Status is Associated With Preserved Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease.
Lee J; Ryu H; Kim YC; Park HC; Ahn C; Lee KB; Kim YH; Kim Y; Han S; Bae EH; Oh KH; Oh YK
J Ren Nutr; 2023 Jul; 33(4):529-537. PubMed ID: 36965751
[TBL] [Abstract][Full Text] [Related]
20. A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease.
Kocyigit I; Yilmaz MI; Unal A; Ozturk F; Eroglu E; Yazici C; Orscelik O; Sipahioglu MH; Tokgoz B; Oymak O
Am J Nephrol; 2013; 38(3):218-25. PubMed ID: 23988725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
